ACTU
Actuate Therapeutics Inc.

101
Loading...
Loading...
News
all
press releases
News Placeholder
HC Wainwright Has Negative Forecast for ACTU FY2029 Earnings
Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) - HC Wainwright reduced their FY2029 EPS estimates for shares of Actuate Therapeutics in a note issued to investors on Wednesday, November 19th...
MarketBeat·15h ago
News Placeholder
Actuate Therapeutics (NASDAQ:ACTU) Shares Up 0.5% After Better-Than-Expected Earnings
Actuate Therapeutics (NASDAQ:ACTU) Stock Price Up 0.5% Following Strong Earnings...
MarketBeat·5d ago
News Placeholder
Actuate Therapeutics (NASDAQ:ACTU) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Actuate Therapeutics (NASDAQ:ACTU - Get Free Report) announced its earnings results on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·6d ago
News Placeholder
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026.
Stocktwits·2mo ago

Latest ACTU News

View

Advertisement|Remove ads.

Advertisement|Remove ads.